from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1251c/-

LFCtreatmentdescriptionclass of inhibitor

0.412

Amikacinug/mL Amikacintranslation

-0.081

Cap5-10ug/mL Capreomycintranslation

-0.271

Rox10-50 ug/mL Roxithromycintranslation

0.815

SM2-5 ug/mL Streptomycintranslation

0.292

Tet5-10 ug/mL Tetracyclinetranslation

0.357

Rif0.2-5ug/mL Rifampicintranscription

-0.143

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.259

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.030

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.191

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.748

Clofazimine10-13 ug/mL Clofaziminerespiration

0.393

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.335

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.405

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.423

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.366

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.319

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.344

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.915

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.096

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.207

KCN5-20 ug/mL Potassium cyaniderespiration

0.720

NaN30.2-2 mM Sodium aziderespiration

-1.701

Nigericin50 uM Nigericinrespiration

-0.431

TRC10-150 ug/mL Triclosanrespiration

0.769

TRZ10-25 ug/mL Thioridazinerespiration

-0.355

Valinomycin0.5-10 uM Valinomycinrespiration

-0.235

ZnSO42 mM ZnSO4respiration

-0.216

menadione6-10 ug/mL Menadionerespiration

-1.675

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.191

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.072

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.035

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.040

NRP_1Non-replicating persistence stage 1dosRassociated

0.339

Amp0.2mg/mL AmpicillincellWall

0.741

Cephalexin20-100 ug/mL CephalexincellWall

0.026

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.532

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.121

EMB10-20 ug/mL EthambutolcellWall

0.373

Eta12-40 ug/mL EthionamidecellWall

1.261

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.214

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.495

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.152

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.704

BZA0.12 mg/mL BenzamidearomaticAmides

-0.229

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.473

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.203

H2O24 mM hydrogen peroxideDNAdamaging

0.444

Levo10 ug/mL LevofloxacinDNAdamaging

-0.389

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.353

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.344

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.229

UVUV-irradiationDNAdamaging

0.107

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.779

Antimycin12.5-50 ug/mL Antimycin A?

0.287

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.341

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.359

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.581

PA8240.2-2 ug/mL PA-824?

0.350

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.360

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.799

Verapamil50 uM Verapamil?

1.285

mercaptoethanol2 mM 2-Mercaptoethanol?

0.053

methoxatin10-20 ug/mL Methoxatin?